Manufacturing: Page 41
-
PCT spears a cancer deal with Adaptimmune
The new agreement expands an existing collaboration between the two companies, and will cover cancer immunotherapy manufacturing.
By Suzanne Elvidge • Sept. 22, 2016 -
Momenta, BioFactura team up on biosimilars
With a number of aging, yet still top-selling, biologics nearing patent expiry, biosimilar development in the U.S. is gaining steam.
By Suzanne Elvidge • Sept. 22, 2016 -
Horizon opens up cell lines to researchers
A partnership with two high-profile research organizations will allow groups to license access to the cell lines for research into biologics.
By Lisa LaMotta • Sept. 15, 2016 -
Lonza builds out gene therapy offerings
A new licensing deal with Mass Eye and Ear will give the Swiss contracting giant access to an AAV vector platform, important for development of new gene therapies.
By Ned Pagliarulo • Sept. 15, 2016 -
Novo pulls 71,000 kits of glucagon med from US market
The Danish drugmaker issued the recall of GlucaGen Hypokits after two customer complaints flagged detached needles.
By Ned Pagliarulo • Sept. 15, 2016 -
CMOs speed Citius Pharmaceuticals into Phase 3
Citius has brought on two CMOs to produce Mino-Lok for the clinical trial, which is slated to begin in 2017.
By Suzanne Elvidge • Sept. 15, 2016 -
Avara snaps up AstraZeneca plant
AstraZeneca had planned to close the England-based plant, which employs more than 200 employees.
By Lisa LaMotta • Sept. 8, 2016 -
Fresh off new funding, Moderna plans new manufacturing plant
The Cambridge-based biotech recently raised $474 million to add to its impressive cash haul.
By Ned Pagliarulo • Sept. 8, 2016 -
Cambrex expands manufacturing in Sweden
The New Jersey-based small molecule manufacturer opened a new facility to build out its large-scale capacity.
By Lisa LaMotta • Sept. 8, 2016 -
FDA
FDA renews ban on Indian drugmaker after fresh violations
Pan Drugs failed to maintain basic sanitary standards at its Vandodara facility, and FDA inspectors uncovered evidence of falsified documents.
By Ned Pagliarulo • Sept. 8, 2016 -
Onconova cuts staff further to save cash
The newest layoffs follow earlier job cuts back in February and are aimed at conserving funds in the wake of Baxalta cutting ties on a collaboration.
By Suzanne Elvidge • Sept. 1, 2016 -
In wake of generics deal, Teva to close New York plant
Closure of the Ponoma, New York-based facility would affect approximately 80 jobs, the Israeli generics maker said.
By Ned Pagliarulo • Sept. 1, 2016 -
Theranos stumbles in efforts to sell Zika test: report
The troubled blood-testing company withdrew its application for emergency use of the test after an FDA inspection, according to news reports.
By Ned Pagliarulo • Sept. 1, 2016 -
Frontida warned by FDA over GMP violations
The facility in question, while under ownership by Sun Pharma, had knowingly released 27 batches of potentially contaminated API, according to U.S. regulators.
By Suzanne Elvidge • Aug. 30, 2016 -
Actavis pulls Patheon-made pills
The generic drug maker, now part of Teva, pulled several lots of pills after tests revealed they didn't meet expectations.
By Lisa LaMotta • Aug. 25, 2016 -
Sagent recalls injectable antibiotic
One lot of Oxacillin is being pulled from the market after metal particulate was found in a vial of the drug.
By Ned Pagliarulo • Aug. 25, 2016 -
Fresenius Kabi invests $250M in manufacturing expansion
The investment will add production capacity at the German manufacturer's Illinois site.
By Suzanne Elvidge • Aug. 25, 2016 -
Automation drives Zenith's US expansion
Manufacturing software solutions provider Zenith Technologies recently expanded its footprint, opening two new offices on the West Coast.
By Suzanne Elvidge • Aug. 25, 2016 -
Pfizer to shed four Hospira sites
The move will lay off 104 people in Hospira’s former sites in Atlanta, Dallas, Los Angeles and King of Prussia, PA.
By Kirell Lakhman • Aug. 22, 2016 -
Piramel buys contract manufacturer Ash Stevens
The Indian company is expanding its North American presence and ability to manufacture different types of pharmaceuticals.
By Lisa LaMotta • Aug. 18, 2016 -
Deep Dive
MI Labs to biotechs: Call us home
Founded last year, Mass Innovation Labs styles itself as a “chief operating officer” for emerging companies.
By Ned Pagliarulo • Aug. 16, 2016 -
Novartis expands plant ahead of expected growth
The big pharma is more than doubling its capacity at one of its biologics plants to prepare for expected strong product sales.
By Lisa LaMotta • Aug. 16, 2016 -
Sponsored by ICON plc
ICPE Booth A2 - ICON
Discover a convergence model driven by real-world intelligence and patient-centric innovation.
By Ramita Tandon, Executive Vice President Commercialisation & Outcomes, ICON plc • Aug. 16, 2016 -
FDA
Valeant nearing resolution of CRL, Papa says
The FDA initially rejected Valeant's application for approval of an eye drug over violations at a manufacturing facility in Tampa, FL.
By Lisa LaMotta • Aug. 11, 2016 -
NIH shuts down facility used to produce drugs for clinical trials
Inspections by the FDA last year revealed serious violations of proper manufacturing processes, prompting a sweeping review of all sterile production at the national medical research agency.
By Ned Pagliarulo • Aug. 10, 2016
Previous
